Related Experiment Video

Updated: Jul 18, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Cardiovascular genomics: a current overview of in vivo and in vitro studies

Devi Mariappan1, Johannes Winkler, Jürgen Hescheler

  • 1Center of Physiology and Pathophysiology Institute of Neurophysiology, Robert-Koch Strasse 39, Cologne, Germany.

Stem Cell Reviews
|December 5, 2006
PubMed

Insights

Cardiovascular system development involves complex cellular interactions. This review explores key factors, genes, and genomics regulating embryonic heart and vessel formation in mammals.

Area of Science:

  • Developmental Biology
  • Cardiovascular Science
  • Genomics

Background:

  • The cardiovascular system is the first to develop during embryogenesis.
  • Its formation requires intricate coordination of cell differentiation and interaction.
  • Embryonic stem cells offer a valuable model for studying mammalian cardiovascular development.

Purpose of the Study:

  • To review extrinsic and intrinsic factors regulating cardiovascular development.
  • To highlight the role of transcription factors, receptors, and signaling pathways.
  • To emphasize the contribution of cardiovascular genomics and gene expression.

Main Methods:

  • Review of in vivo and in vitro studies on cardiovascular development.
  • Analysis of molecular and cellular mechanisms.
  • Focus on genomic and gene expression data.

Main Results:

  • Identified key extrinsic soluble factors and intrinsic transcription factors.
  • Detailed signal transduction pathways and regulatory genes.
  • Highlighted the importance of cardiovascular genomics in understanding development and disease.

Conclusions:

  • Cardiovascular development is a multifaceted process regulated by numerous factors.
  • Genomic approaches provide critical insights into cardiovascular system formation.
  • Understanding these mechanisms is crucial for developmental and pathophysiological studies.

More Related Videos

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart06:07

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Overview of the Cardiovascular System01:14

Overview of the Cardiovascular System

The cardiovascular system is a vital transportation system in the body. It comprises the heart and blood vessels and facilitates the exchange of gases, nutrients, and waste products.
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...